You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華康生物醫學(08622.HK)與春雷生物組合營 拓診斷男性生育能力市場業務
阿思達克 04-08 16:49
華康生物醫學(08622.HK)公布,直接全資子公司華康香港後與春雷生物簽訂了諒解備忘錄,內容有關可能於香港成立一間合資公司,其中華康香港佔55%,春雷生物佔45%。

華康香港在合資公司成立後六個月內,向合資公司出資不超過550萬元以用作成立合資集團、研發活動和一般營運資金;春雷生物向合資公司授予若干春雷生物知識產權的獨家許可和權利,以應用於合資公司在男性生育能力市場業務,及有關男性生育力領域的所有研發成果將實現和商業化,而該等許可和權利估值之總價值為不少於450萬元。

合資公司以微流控技術和即時檢驗生物醫學測試的使用及應用於診斷男性生育能力的相關研發;及商業化若干男性生育能力市場的微流控診斷產品。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account